Medical educational program

• Explain lipid components and normal lipid levels
• Discuss dyslipidaemia, along with its classification and risk factors
• Elaborate on the association between dyslipidaemia and atherosclerosis

Course Duration:
30 minutes

auID:
4058561

• Elaborate on the approach to a patient with dyslipidaemia
• Discuss the prevention of dyslipidaemia
• Explain the pharmacological and non-pharmacological methods of treatment of dyslipidaemia

Course Duration:
30 minutes

auID:
4058563

• Briefly discuss the overview of the management of dyslipidaemia
• Discuss the effect on statins on lipid and lipoprotein levels
• Explain the role and clinical evidences for rosuvastatin in the management of dyslipidaemia

Course Duration:
30 minutes

auID:
4058565

• Dyslipidaemia is a modifiable yet highly prevalent risk factor for atherosclerotic disease and its complications, including coronary heart disease (CHD), myocardial infarction (MI), stroke, peripheral vascular disease and cardiac death.
• The management of dyslipidaemia primarily focuses on controlling elevated LDL-C levels based on guideline recommendations, along with a secondary focus on correcting other lipid levels such as non-high-density lipoprotein cholesterol (non-HDL-C), HDL-C and triglycerides (TGs).

Course Duration:
30 minutes

auID:
4058567